Skip to the page

Data / Drug companies / Non-Standardized Insect Venom Allergenic Extract

Non-Standardized Insect Venom Allergenic Extract drugs: 6 drugs from 5 companies in the FDA NDC directory

Non-Standardized Insect Venom Allergenic Extract is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 19 products in this class from 5 companies, covering 6 drugs by generic name. The main marketing category is biologics (BLA), and the newest product started marketing on January 1, 1990.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

  • 5Companies
  • 19Products
  • 6Drugs by generic name

Drugs in the Non-Standardized Insect Venom Allergenic Extract class

Ranked by number of companies that list the drug.

DrugProducts hereCompanies listing it
Solenopsis invicta52
Camponotus pennsylvanicus31
Insects whole body, fire ant mix31
Ant, fire solenopsis invicta21
Fire ant21
Solenopsis richteri21

Companies with the most products in this class

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Greer Laboratories, Inc.8solutionBiologics (BLA)September 15, 1981
Jubilant HollisterStier LLC5injection, solutionBiologics (BLA)April 19, 1941
ALK-Abello, Inc.4injection, solutionBiologics (BLA)January 1, 1965
Dna Labs, Inc.1solutionUnapproved homeopathic productsJanuary 1, 1990
Professional Complementary Health Formulas1liquidUnapproved homeopathic productsAugust 15, 1984

Dosage forms

Dosage formProductsShare
Solution947.4%
Injection, solution947.4%
Liquid15.3%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.